In recent weeks, new articles authored by CRCM teams have been published in leading international scientific journals.

You can find all of our recent publications below.

Team Nunès / Devillier

➡️ A comprehensive review of mechanisms underlying resistance to immune checkpoint inhibitors.

➡️ Preoperative lymphocyte signature predicts pancreatic fistula after pancreatoduodenectomy.

Team Pasquier / André

➡️ Building a new arsenal: repurposed drugs and metronomic chemotherapy against medulloblastoma.

Team Benzekry / Ciccolini

➡️ Model-Driven Optimization of Subcutaneous Polymer Prodrugs Achieves Cancer Remission in Mice.

Team Mamessier / Bertucci

➡️ Follicular and follicle center-cell lymphomas: A family between kinship and diversity.

➡️ Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value.

➡️ [Sugemalimab as monotherapy for unresectable stage III non-small cell lung cancer with PD-L1 expression≥1%, without oncogenic driver alterations and without progression after chemoradiation].

Team Modesti

➡️ Human DNA-PKcs promotes broken DNA-end structure independence during NHEJ.

Team Coulon

➡️ Aneuploidy alleviates the cell proliferation defect caused by mutations affecting origin licensing in Saccharomyces cerevisiae.